Ozbay G - Search Results

1

Tabak F, Mert A, Ozaras R, Biyikli M, Ozturk R, Ozbay G, Senturk H, Aktuglu Y. Tabak F, et al. Among authors: ozbay g. J Clin Gastroenterol. 2002 May-Jun;34(5):585-6. doi: 10.1097/00004836-200205000-00022. J Clin Gastroenterol. 2002. PMID: 11960076 Review.

2

Ornidazole-induced liver damage: report of three cases and review of the literature.

Tabak F, Ozaras R, Erzin Y, Celik AF, Ozbay G, Senturk H. Tabak F, et al. Among authors: ozbay g. Liver Int. 2003 Oct;23(5):351-4. doi: 10.1034/j.1478-3231.2003.00860.x. Liver Int. 2003. PMID: 14708896 Review.

3

The prevalence of hepatic granulomas in chronic hepatitis C.

Ozaras R, Tahan V, Mert A, Uraz S, Kanat M, Tabak F, Avsar E, Ozbay G, Celikel CA, Tozun N, Senturk H. Ozaras R, et al. Among authors: ozbay g. J Clin Gastroenterol. 2004 May-Jun;38(5):449-52. doi: 10.1097/00004836-200405000-00011. J Clin Gastroenterol. 2004. PMID: 15100526

4

Therapeutic vaccination in chronic hepatitis B.

Senturk H, Tabak F, Akdogan M, Erdem L, Mert A, Ozaras R, Sander E, Ozbay G, Badur S. Senturk H, et al. Among authors: ozbay g. J Gastroenterol Hepatol. 2002 Jan;17(1):72-6. doi: 10.1046/j.1440-1746.2002.02652.x. J Gastroenterol Hepatol. 2002. PMID: 11895556 Clinical Trial.

5

Acute exacerbation during interferon alfa treatment of chronic hepatitis B: frequency and relation to serum beta-2 microglobulin levels.

Akdogan M, Senturk H, Mert A, Tabak F, Ozbay G. Akdogan M, et al. Among authors: ozbay g. J Gastroenterol. 2003;38(5):465-70. doi: 10.1007/s00535-002-1083-6. J Gastroenterol. 2003. PMID: 12768389

6

Melatonin reduces dimethylnitrosamine-induced liver fibrosis in rats.

Tahan V, Ozaras R, Canbakan B, Uzun H, Aydin S, Yildirim B, Aytekin H, Ozbay G, Mert A, Senturk H. Tahan V, et al. Among authors: ozbay g. J Pineal Res. 2004 Sep;37(2):78-84. doi: 10.1111/j.1600-079X.2004.00137.x. J Pineal Res. 2004. PMID: 15298665

7

Prevalence of hepatic granulomas in chronic hepatitis B.

Tahan V, Ozaras R, Lacevic N, Ozden E, Yemisen M, Ozdogan O, Mert A, Tabak F, Avsar E, Celikel CA, Ozbay G, Kalayci C, Senturk H, Tozun N. Tahan V, et al. Among authors: ozbay g. Dig Dis Sci. 2004 Oct;49(10):1575-7. doi: 10.1023/b:ddas.0000043366.18578.15. Dig Dis Sci. 2004. PMID: 15573907

8

Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: a randomized trial.

Canbakan B, Senturk H, Tabak F, Akdogan M, Tahan V, Mert A, Sut N, Ozaras R, Midilli K, Ozbay G. Canbakan B, et al. Among authors: ozbay g. J Gastroenterol Hepatol. 2006 Apr;21(4):657-63. doi: 10.1111/j.1440-1746.2006.04082.x. J Gastroenterol Hepatol. 2006. PMID: 16677149 Clinical Trial.

9

Clinicopathologic features of dual chronic hepatitis B and C infection: a comparison with single hepatitis B, C and delta infections.

Senturk H, Tahan V, Canbakan B, Dane F, Ulger Y, Ozaras R, Tabak F, Ozbay G. Senturk H, et al. Among authors: ozbay g. Ann Hepatol. 2008 Jan-Mar;7(1):52-8. Ann Hepatol. 2008. PMID: 18376366 Free article.

10

Hepatic apoptotic markers are not predictors for the virological response to interferon-based therapy in chronic hepatitis C patients.

Ozaras R, Tahan V, Ozbay G, Ozturk R, Yenice N, Celikel ÇA, Midilli K, Gucin Z, Fincanci M, Tozun N, Senturk H, Osme A, Tabak F, Mert A. Ozaras R, et al. Among authors: ozbay g. Eur J Gastroenterol Hepatol. 2015 Sep;27(9):1057-62. doi: 10.1097/MEG.0000000000000397. Eur J Gastroenterol Hepatol. 2015. PMID: 26011229

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page